Rapamycin impairs endothelial cell function in human internal thoracic arteries

David C Reineke1, Else Müller-Schweinitzer2,3, Bernhard Winkler1,3

  • 1Department of Cardiovascular Surgery, University Hospital Berne, Bern, CH-3010, Switzerland.

Summary

Rapamycin treatment impairs endothelial function in human coronary arteries by reducing relaxation and down-regulating Akt-phosphorylation via the mTOR signaling axis, without causing endothelial cell injury.

Related Concept Videos